Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE94409 |
Targeting the HBZ Viral Oncoprotein Transcriptional Network in Adult T-cell leukemia/lymphoma
|
|
28 | Louis M. Staudt | Jul 10, 2018 | |||
GSE99276 |
Divergent Mechanisms of Oncogenic B Cell Receptor Signaling in Lymphoma
|
|
8 | Louis M. Staudt | May 01, 2018 | |||
GSE93291 |
A new molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies
|
|
123 |
|
Louis M. Staudt | Mar 17, 2017 | ||
GSE86265 |
Epigenetic Gene Regulation by Janus Kinase 1 in Diffuse Large B Cell Lymphoma (Agilent)
|
|
4 | Louis M. Staudt | Feb 08, 2017 | |||
GSE86266 |
Epigenetic Gene Regulation by Janus Kinase 1 in Diffuse Large B Cell Lymphoma
|
|
8 |
|
Louis M. Staudt | Feb 08, 2017 | ||
GSE75650 |
A druggable TCF4- and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm
|
|
16 | Louis M. Staudt | Nov 15, 2016 | |||
GSE73281 |
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma (Agilent Arrays)
|
|
20 | Louis M. Staudt | Sep 01, 2016 | |||
GSE79292 |
Regulation of normal B cell differentiation and malignant B cell survival by OCT2 (expression)
|
|
57 | Louis M. Staudt | May 25, 2016 | |||
GSE79482 |
Regulation of normal B cell differentiation and malignant B cell survival by OCT2
|
|
66 |
|
Louis M. Staudt | May 25, 2016 | ||
GSE68505 |
ATM-deficient B cell lymphomas
|
|
32 | Louis M. Staudt | Dec 09, 2015 | |||
GSE64586 |
FOXP1 in ABC DLBCL
|
|
24 | Louis M. Staudt | Dec 01, 2015 | |||
GSE63029 |
Highly Potent and Selective Interleukin-1 Receptor-Associated Kinase 4 Inhibitors for the Treatment of Lymphoid Malignancies
|
|
16 | Louis M. Staudt | Nov 01, 2015 | |||
GSE58756 |
Cell intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses
|
|
16 | Louis M. Staudt | Mar 04, 2015 | |||
GSE58791 |
Blockade of oncogenic IkappaB kinase activity in ABC DLBCL by small molecule BET protein inhibitors
|
|
12 | Louis M. Staudt | Aug 01, 2014 | |||
GSE47147 |
Oncogenic MyD88 Mutants Require Toll-like Receptors
|
|
4 | Louis M. Staudt | May 21, 2014 | |||
GSE53786 |
DLBCL cell-of-origin by gene expression in FFPET
|
|
119 |
|
Louis M. Staudt | Jan 14, 2014 | ||
GSE41034 |
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
|
|
16 | Louis M. Staudt | Sep 20, 2012 | |||
GSE32456 |
Co-addiction to IRF4 and SPIB in ABC-DLBCL
|
|
32 | Louis M. Staudt | Aug 16, 2012 | |||
GSE33012 |
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
|
|
8 | Louis M. Staudt | Aug 16, 2012 | |||
GSE35163 |
Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics
|
|
32 | Louis M. Staudt | Aug 16, 2012 |